These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Zhang R; Tremblay TL; McDermid A; Thibault P; Stanimirovic D Glia; 2003 Apr; 42(2):194-208. PubMed ID: 12655603 [TBL] [Abstract][Full Text] [Related]
8. [OMICS and biomarkers of glial tumors]. Idbaih A Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780 [TBL] [Abstract][Full Text] [Related]
9. Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme. Schuhmann MU; Zucht HD; Nassimi R; Heine G; Schneekloth CG; Stuerenburg HJ; Selle H Eur J Surg Oncol; 2010 Feb; 36(2):201-7. PubMed ID: 19674866 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal Bottom-Up Proteomics of Serum, Serum Extracellular Vesicles, and Cerebrospinal Fluid Reveals Candidate Biomarkers for Early Detection of Glioblastoma in a Murine Model. Greco F; Anastasi F; Pardini LF; Dilillo M; Vannini E; Baroncelli L; Caleo M; McDonnell LA Molecules; 2021 Oct; 26(19):. PubMed ID: 34641541 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel human glioblastoma-specific transcripts by serial analysis of gene expression data mining. Su Y; Xiong J; Bing Z; Zeng X; Zhang Y; Fu X; Peng X Cancer Biomark; 2013; 13(5):367-75. PubMed ID: 24440977 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers of glioblastoma multiforme. Nicolaidis S Metabolism; 2015 Mar; 64(3 Suppl 1):S22-7. PubMed ID: 25468141 [TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions. Polisetty RV; Gautam P; Sharma R; Harsha HC; Nair SC; Gupta MK; Uppin MS; Challa S; Puligopu AK; Ankathi P; Purohit AK; Chandak GR; Pandey A; Sirdeshmukh R Mol Cell Proteomics; 2012 Jun; 11(6):M111.013565. PubMed ID: 22219345 [TBL] [Abstract][Full Text] [Related]
14. Glioblastoma biomarkers from bench to bedside: advances and challenges. Farias-Eisner G; Bank AM; Hwang BY; Appelboom G; Piazza MA; Bruce SS; Sander Connolly E Br J Neurosurg; 2012 Apr; 26(2):189-94. PubMed ID: 22176646 [TBL] [Abstract][Full Text] [Related]
15. Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics. Miyauchi E; Furuta T; Ohtsuki S; Tachikawa M; Uchida Y; Sabit H; Obuchi W; Baba T; Watanabe M; Terasaki T; Nakada M PLoS One; 2018; 13(3):e0193799. PubMed ID: 29513714 [TBL] [Abstract][Full Text] [Related]